Country intelligence
Deals, market moves, science and policy across the platform tagged to Ireland.
A narrow access programme for three conditions, with few patients treated in practice.
Patients can access cannabis either through MCAP or via a ministerial licence; the licence route is lengthy and bureaucratic, while MCAP is limited to three conditions — MS spasticity, chemotherapy nausea and neuropathic pain — each requiring a relevant specialist.
MCAP patients may be reimbursed if they qualify for a health card, whereas ministerial-licence patients pay in full; products are often imported on a per-prescription basis, raising costs.
Nothing tagged to Ireland yet. Tag deals, studies or articles with this country to see them here and on the map.
